TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT05850013

Intervention type: DEVICE
Intervention: Lifelight Junior
Description: Lifelight® is an app developed by xim that measures VS including heart rate, respiratory rate and blood pressure. All you need to do to have these vital signs measured is look at your smartphone or tablet camera for 20-40 seconds. The app has used data from over 1 million heartbeats to learn how to measure these vital signs in adults. The technology is already available for doctors and nurses to use with adult patients in some specific scenarios

Intervention type: DEVICE
Intervention: Lifelight Junior
Description: Lifelight® is an app developed by xim that measures VS including heart rate, respiratory rate and blood pressure. All you need to do to have these vital signs measured is look at your smartphone or tablet camera for 20-40 seconds. The app has used data from over 1 million heartbeats to learn how to measure these vital signs in adults. The technology is already available for doctors and nurses to use with adult patients in some specific scenarios
Study: NCT05333003

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Semaglutide
Description: The semaglutide dose will start with 0.25 mg/week, and slowly increased every four weeks as tolerated up to a maximal dose of 2 mg/week

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo will be provided to participants
Study: NCT04739904

Intervention type: OTHER
Intervention: Normoxia
Description: 48 hours experimental protocol conducted at sea level

Intervention type: OTHER
Intervention: Normobaric hypoxia
Description: 24 hours experimental protocol conducted in a normobaric hypoxic facility

Intervention type: OTHER
Intervention: Normobaric hypoxia
Description: 24 hours experimental protocol conducted in a normobaric hypoxic facility

Intervention type: OTHER
Intervention: Hypobaric hypoxia
Description: 72 hours experimental protocol conducted at terrestrial altitude

Intervention type: OTHER
Intervention: Hypobaric hypoxia
Description: 72 hours experimental protocol conducted at terrestrial altitude
Study: NCT06241820

Intervention type: PROCEDURE
Group type: OTHER
Intervention: Lumbar Sympathetic Ganglion Block
Description: A needle will be inserted at the L3 on the side experiencing pain, either right or left, under fluoroscopy guidance. Once the needle is positioned in front of the desired vertebral body, its location is confirmed using a contrast medium. If the position is well visualized in lateral and anteroposterior (AP) views, 7 mL of 0.5% ropivacaine will be injected.
Study: NCT06104722

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: High-intensity Copenhagen adduction exercise
Description: Copenhagen adduction exercise is an eccentric strengthening protocol of hip adductors and suitable for groin injury prevention and rehabilitation.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Low-intensity Copenhagen adduction exercise
Description: Copenhagen adduction exercise is an eccentric strengthening protocol of hip adductors and suitable for groin injury prevention and rehabilitation.
Study: NCT06249022

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Rehabilitation therapy
Description: Including:Acupuncture: Regular acupuncture treatment that can prevent muscle atrophy, improve circulation, and have a stimulating effect. Exercise therapy: Training that focused on limb movements or joint mobilization to prevent muscle contracture, reduce joint mobility, improve spasms, and promote blood circulation. Others: Regular turning, back patting, and position changes performed by caregivers.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Rehabilitation therapy
Description: Including:Acupuncture: Regular acupuncture treatment that can prevent muscle atrophy, improve circulation, and have a stimulating effect. Exercise therapy: Training that focused on limb movements or joint mobilization to prevent muscle contracture, reduce joint mobility, improve spasms, and promote blood circulation. Others: Regular turning, back patting, and position changes performed by caregivers.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Intermittent Oro-esophageal Tube Feeding
Description: Based on this, the patients in the observation group were given nutrition support with Intermittent Oro-esophageal Tube Feeding (Medical Device No. 20010234, developed by the Swallowing Disorders Research Institute of Zhengzhou University). The entire feeding process strictly followed the standard procedure of Intermittent Oro-esophageal Tube Feeding. During the feeding process, patients were maintained in a semi-recumbent position with their head elevated, facilitating the placement of the tube into the oral cavity along one side, with the chin brought close to the manubrium sterni.

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Nasogastric tube feeding
Description: The patients in the control group were provided nutrition support with Nasogastric tube feeding, while the feeding process strictly followed the relevant guideline. During the treatment, the patients remained in a continuous state of tube indwelling, receiving feeding every 2-3 hours with a maximum feeding volume of 200ml, of which the contents were consistent with the observation group. The entire feeding process was conducted by trained nursing staff. Besides, the tube was replaced by a new one every 5-7 days.
Study: NCT04845672

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: 2% chlorhexidine gluconate
Description: Children in 2% chlorhexidine gluconate group , which is the routine practice of the hospital, and a wiping bath in accordance with the bath protocol specified. The bath procedure will take 10-15 minutes. Before wiping bath swab sample will provide from armpit and groin with circular manner and 6 hours later swap sample will be provided from the same areas again. The swab sample taken will be planted on blood agar medium and kept at + 4-8 ℃ for an average of 18-24 hours. After it is planted on blood agar medium, it will be kept at + 4-8 ℃ for an average of 18-24 hours . A total of 12 swab samples will be taken for 3 days from each child and from the same areas, body flora will be evaluated.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: soap-free body cleaning solution
Description: Children in a wiping bath with soap-free body washing solution group, and a wiping bath in accordance with the bath protocol specified. The bath procedure will take 10-15 minutes. Before wiping bath swab sample will provide from armpit and groin with circular manner and 6 hours later swap sample will be provided from the same areas again. The swab sample taken will be planted on blood agar medium and kept at + 4-8 ℃ for an average of 18-24 hours. After it is planted on blood agar medium, it will be kept at + 4-8 ℃ for an average of 18-24 hours . A total of 12 swab samples will be taken for 3 days from each child and from the same areas, body flora will be evaluated.
Study: NCT04839406

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Structured support of caregivers at the ICU
Description: Structured support of caregivers at the ICU provided by a trained group of 10-15 ICU nurses
Study: NCT04815538

Intervention type: BEHAVIORAL
Intervention: the subscale of Health-Promoting Lifestyle Profile II
Description: Nutritional health behavior included the following nine items: choose a low-fat diet; limit the use of sugars; eat servings of bread, cereal, and rice; eat servings of fruit; eat servings of vegetables; eat servings of meat, poultry, fish, dietary guidelines

Intervention type: BEHAVIORAL
Intervention: the subscale of Health-Promoting Lifestyle Profile II
Description: Nutritional health behavior included the following nine items: choose a low-fat diet; limit the use of sugars; eat servings of bread, cereal, and rice; eat servings of fruit; eat servings of vegetables; eat servings of meat, poultry, fish, dietary guidelines
Study: NCT05739552

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Telerehabilitation program
Description: Application of customised respiratory and/or motor rehabilitation exercises to be carried out directly at the patients' home after hospital discharge in order to evaluate its effects.
Study: NCT04771689

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Buprenorphine/Naloxone
Description: Subjects will be randomized into one of the treatment groups and will follow the assigned medication schedule for the length of their hospital stay, at least 6 days.
Study: NCT04941118

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Injection of dextrose, local anesthetic and saline to the myofascial trigger point
Description: An injection of 5 ml of 5% dextrose prolotherapy using 2.5 ml 10% dextrose, 1 ml 2% local anesthetic (lidocaine), 1.5 ml 0.9% saline will be administered to the active group from at least 10 trigger points.

Intervention type: DRUG
Group type: SHAM_COMPARATOR
Intervention: Local anesthetic and saline injection to the myofascial trigger point
Description: A total of 5 ml of solution created by using 4 ml of 0.9% saline and 1 ml of 2% local anesthetic (lidocaine) will be administered to the control group, with at least 10 trigger points.
Study: NCT05842746

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Elemene
Description: Elemene of 20ml is given orally, three times a day, for 28 consecutive days (as a cycle), for 6 cycles.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo (with the same appearance and flavor with Elemene) of 20ml is given orally, three times a day, for 28 consecutive days (as a cycle), for 6 cycles.
Study: NCT05945381

Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: GIC on MIH
Description: Subjects will be seated in a dental chair set-up using standard infection control guidelines. Then the study and its objectives will be explained to the patients and their caregivers. The tooth will be cleaned with a prophylactic paste and brush for complete debris and plaque removal. The tooth will then be dried with a cotton roll, as the patient doesn't tolerate the air-drying (which is the case in SCASS 2 and 3). Moisture control will be kept with cotton roll, the tooth is then sealed with a hard setting glass-ionomer cement (IonoStar Plus, VOCO, Germany) followed by an application of a surface coat (Easy Glaze, VOCO, Germany) for moisture and dehydration protection after sealant application. The distributed questionnaire will include questions regarding the attitude of the child's caregiver to the idea and their estimation of the child's fair regarding dental visit.
Study: NCT06128850

Intervention type: OTHER
Intervention: disease
Description: compare to diseases

Intervention type: OTHER
Intervention: disease
Description: compare to diseases

Intervention type: OTHER
Intervention: disease
Description: compare to diseases
Study: NCT05402215

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: The flipped classroom model was used to teach students' clinical practice skills.
Description: Videos for clinical applications have been prepared by researchers. These prepared videos were shared with the students in the experimental group one week before the lesson day of each application for preliminary study and the students were asked to work on these videos. On the day of the lesson, group work, question-answer and discussion activities were held with the students in the classroom environment. At the end of the lesson, the students were asked to do the applications on the simulation models of the application and the checklists were filled.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: control group
Description: To the students in the control group, the application was explained by the researcher (instructor conducting the course) using presentation and demonstration methods. Each application was made on different days. The prepared checklists were filled by the other researcher.
Study: NCT04981301

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Quadratus Lumborum Block
Description: The block procedure will be applied after the surgery and before extubation with patients in the prone position by using US (Vivid Q, GE Healthcare, US). Under aseptic conditions using 10% povidone iodine, the convex probe will be covered with a sterile sheath and a 22G, 100 mm block needle (Braun Stimuplex Ultra 360, Germany) will be used. After visualizing the abdominal muscles with the anterior approach, the needle will be punctured in the Petit triangle and 5 ml of saline will be injected into the anterolateral border of the quadratus lumborum muscle. After the block location is confirmed, 15 ml of 0.25% bupivacaine will be injected. The same process will be applied to the opposite side (30 ml totally).
Study: NCT05740046

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: INTORUS
Description: INTERVENTION PROTOCOL WITH INTORUS
Study: NCT06301334

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Bupivacaine 0.25% Injectable Solution
Description: Group CTB (n=30): patients included in this group will receive unilateral US-guided CTB after general anesthesia. The CTB will be performed by using 20 ml bupivacaine 0.25% Group ESPB (n=30): patients included in this group will receive unilateral US-guided ESPB after general anesthesia. The ESB will be performed by using 20 ml bupivacaine 0.25%

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Bupivacaine 0.25% Injectable Solution
Description: Group CTB (n=30): patients included in this group will receive unilateral US-guided CTB after general anesthesia. The CTB will be performed by using 20 ml bupivacaine 0.25% Group ESPB (n=30): patients included in this group will receive unilateral US-guided ESPB after general anesthesia. The ESB will be performed by using 20 ml bupivacaine 0.25%
Study: NCT04833543

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Robotic Mobility Device (REX)
Description: A self supporting robotic mobility device (REX) will be utilized. It is a Class I device, and it is classified as powered exercise equipment meant for anyone that requires use of a wheelchair for mobility who has difficulty with standing and walking. The participant will be supported securely within the device using a pelvic harness, and thigh and calf cuffs. The device will be operated under the supervision of a device trained physical therapist and therapy technician. The participant will be transferred into the device in a seated position. Once aligned properly and strapped in, the participant will be passively moved by the device into standing and walking positions. To provide constant vestibular input, a variety of mobility functions will be performed including standing, sitting, walking, turning, shuffling (side-stepping), and backwards stepping.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Tilt Table
Description: A tilt table is a table with a footplate that can be tilted at different angles. The participant will lie flat on the table and straps will be placed to stabilize the trunk and lower extremities. The inclination of the tilt table will be adjusted from a horizontal to a vertical position to allow the participant to attain and maintain a standing or partial-standing position. Sessions will be supervised by a physical therapist and therapy technician.
Study: NCT06440720

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: ELDOA ,UPPER THORACIC MOBILIZATION AND MOBILITY EXERCISE
Description: Already mentioned

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: ELDOA ,UPPER THORACIC MOBILIZATION AND MOBILITY EXERCISE
Description: Already mentioned
Study: NCT06278350

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: D-2570
Description: Randomized in a 1:1:1:1 ratio through the randomization system, and assigned to D-2570 group~1, group 2, group 3 or placebo group.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: D-2570
Description: Randomized in a 1:1:1:1 ratio through the randomization system, and assigned to D-2570 group~1, group 2, group 3 or placebo group.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: D-2570
Description: Randomized in a 1:1:1:1 ratio through the randomization system, and assigned to D-2570 group~1, group 2, group 3 or placebo group.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Randomized in a 1:1:1:1 ratio through the randomization system, and assigned to D-2570 group~1, group 2, group 3 or placebo group.
Study: NCT01006226

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 64Cu-ATSM PET
Description: 2 64Cu-ATSM PET scan, one pretreatment and one 19-21 days after the first dose of bevacizumab
Study: NCT04771403

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: FMPD AP algorithm
Description: The Fading Memory Proportional Derivative (FMPD) insulin infusion algorithm determines insulin delivery rates based on proportional error, defined as the difference between the current CGM level and the target CGM level, and the derivative error, defined as the rate of change of the CGM. The FMPD algorithm utilizes derivative and proportional glucose errors to determine delivery rates of insulin.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: MPC AP system
Description: The Model Predictive Control (MPC) insulin infusion algorithm contains a model within the controller that takes as an input the aerobic metabolic expenditure in addition to the CGM and meal inputs. The algorithm uses heart rate and accelerometer data collected on the patient's body to calculate metabolic expenditure. The metabolic expenditure then acts on the model for the insulin dynamics, whereby more energy expenditure and longer duration exercise can lead to a more substantial effect of insulin on the CGM.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Dexcom G6 Continuous Glucose Monitoring (CGM) System
Description: The Dexcom G6 CGM measures interstitial glucose through a sensor transmitter. This glucose value is reported to the MPC algorithm during this intervention.
Study: NCT05060354

Intervention type: OTHER
Intervention: Blood draw
Description: Approximately 120 mL whole blood will be collected from each subject at each timepoint

Intervention type: OTHER
Intervention: Blood draw
Description: Approximately 120 mL whole blood will be collected from each subject at each timepoint

Intervention type: OTHER
Intervention: Blood draw
Description: Approximately 120 mL whole blood will be collected from each subject at each timepoint

Intervention type: OTHER
Intervention: Blood draw
Description: Approximately 120 mL whole blood will be collected from each subject at each timepoint
Study: NCT06311162

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Life-Style app
Description: The modules of the Life-Style app are introduced and unlocked sequentially during the first weeks of the intervention phase. Afterwards the modules are fully available. Duration and frequency of app-use is not limited. The parents are accompanied by a coach through the app, who gives regular structured feedback and individual inputs. The coach has access to all data collected in the app.

Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Sham Comparator
Description: The parents get a flyer with information on second-hand smoke exposure and references to smoking cessation programs, and do not have an active app during the main intervention period.
Study: NCT05210569

Intervention type: DEVICE
Intervention: Vivity
Description: Vivity intraocular lens (IOL)
Study: NCT04713735

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Control: Placebo
Description: Placebo

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: bovine lactoferrin supplement
Description: 600 mg
Study: NCT06408818

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Media Aware Parent - Tween
Description: Media Aware Parent - Tween, is an online program for parents of tweens ages 9-12 designed to help parents have effective conversations with their child about body image, sexual development, gender stereotypes, romantic relationships, and media.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Active Control Resource
Description: Parents will have access to medically-accurate information about topics such as body image, sexual development, gender stereotypes, and romantic relationships.
Study: NCT06134258

Intervention type: OTHER
Group type: OTHER
Intervention: mixed meal test
Description: mixed meal test after fasting

Intervention type: OTHER
Group type: OTHER
Intervention: mixed meal test
Description: mixed meal test after fasting
Study: NCT05382754

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Home sleep apnea test
Description: Level II home sleep apnea testing evaluates for obstructive sleep apnea in the home environment with parental supervision.

Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: In-lab polysomnography
Description: Overnight sleep study in the sleep laboratory with continuous monitoring by clinical staff.
Study: NCT05557097

Intervention type: DIAGNOSTIC_TEST
Intervention: Intrapartum sonography
Description: Intrapartum ultrasound performed as an adjunct to clinical examination to assess fetal occiput position prior to performing vacuum delivery
Study: NCT05851092

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HRS-2189 Tablets
Description: HRS-2189 Tablets
Study: NCT06508775

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: MB-CART19.1
Description: Assessment of long-term safety and efficacy of MB-CART19.1 treatment.

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: MB-CART20.1
Description: Assessment of long-term safety and efficacy of MB-CART20.1 treatment.

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: MB-CART2019.1
Description: Assessment of long-term safety and efficacy of MB-CART2019.1 treatment.
Study: NCT06309602

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Free Water Protocol
Description: Intake of plain, un-thickened water is allowed even when a patient has orders for thickened liquids. Risks of pulmonary complications are decreased with use of a strict oral care regimen and timed intake of water related to meals. Patient satisfaction and comfort is increased with ingestion of plain water.
Study: NCT05418166

Intervention type: DRUG
Intervention: Evolocumab
Description: evolocumab 140mg subcutaneous injection after regular take Ticagrelor and Aspirin for 5 days.

Intervention type: DRUG
Intervention: Evolocumab
Description: evolocumab 140mg subcutaneous injection after regular take Ticagrelor and Aspirin for 5 days.
Study: NCT05991648

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Kangaroo Care (skin-to-skin contact)
Description: Skin-to-skin contact between the mother and the child. The naked newborn, wearing only a diaper and a hat, is placed in a vertical position in direct contact between the mother's breasts. An elastic fabric support (made of cotton or synthetic elastic fiber) will be used to facilitate the position.
Study: NCT03058653

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Small fluid boluses of 50 ml
Description: Participants will receive small 50ml boluses of fluid up to 250ml in total. The remainder will be given as infusion pump method at a rate of 1000ml/hour which will complete in 15 minutes. In total, the 500ml will be given over 25 minutes.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: LIDCORapid Monitor
Description: Addition of the LIDCORapid Monitor to measure stroke volume